KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Operating Expenses: 2009-2024

Historic Operating Expenses for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $281.4 million.

  • Dynavax Technologies' Operating Expenses rose 4.33% to $73.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $320.1 million, marking a year-over-year increase of 17.77%. This contributed to the annual value of $281.4 million for FY2024, which is 4.48% up from last year.
  • According to the latest figures from FY2024, Dynavax Technologies' Operating Expenses is $281.4 million, which was up 4.48% from $269.3 million recorded in FY2023.
  • In the past 5 years, Dynavax Technologies' Operating Expenses registered a high of $439.2 million during FY2022, and its lowest value of $114.9 million during FY2020.
  • Over the past 3 years, Dynavax Technologies' median Operating Expenses value was $281.4 million (recorded in 2024), while the average stood at $329.9 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first soared by 165.36% in 2021, then plummeted by 38.68% in 2023.
  • Dynavax Technologies' Operating Expenses (Yearly) stood at $114.9 million in 2020, then skyrocketed by 165.36% to $305.0 million in 2021, then surged by 44.01% to $439.2 million in 2022, then slumped by 38.68% to $269.3 million in 2023, then climbed by 4.48% to $281.4 million in 2024.